Condition : Rheumatoid Arthritis Intervention : Biological: Olokizumab Sponsor : UCB, Inc. Active, not recruiting - verified November 2013

Condition : Osteoarthritis of the Knee Interventions : Other: Neuromuscular training (NEMEX-TJR); Behavioral: Information; Drug: Paracetamol; Drug: Burana; Drug: Pantoprazole; Behavioral: Dietary coun...

The purpose of this study is to verify the efficacy of an 8-week course of manualized Swedish massage for reducing pain and increasing function compared to light-touch bodywork, and usual care, in 222...

This postmarketing study will examine the use of etoricoxib (Arcoxia®) in routine clinical practice in France as well as the use of celecoxib (Celebrex®).

This postmarketing study will examine the use of etoricoxib (Arcoxia®) in routine clinical practice in France as well as the use of celecoxib (Celebrex®).

Condition : Rheumatoid Arthritis Interventions : Biological: PF-05280586; Biological: MabThera; Biological: Rituxan Sponsor : Pfizer Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Biological: PF-05280586; Biological: MabThera; Biological: Rituxan Sponsor : Pfizer Active, not recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Sponsors : UCB, Inc.; UCB Pharma SA; ReSearch Pharmaceutical Services, Inc. Active, not recruiting - verified November 2013

Condition : Rheumatoid Arthritis Interventions : Biological: PF-05280586; Biological: MabThera; Biological: Rituxan Sponsors : Pfizer; Pfizer Active, not recruiting - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Sponsors : UCB, Inc.; UCB Pharma SA; ReSearch Pharmaceutical Services, Inc. Recruiting - verified September 2013